Description
transcription factor-1 (TTF-1) is a 38 kDa constituent of the NKX2 family of
homeodomain transcription factors. TTF-1 is predominantly identified in primary lung
adenocarcinomas and small cell carcinomas. TTF-1 is highly beneficial in lung
malignancies when utilized in conjunction with Desmoglein 3, p40, and Napsin A
antibodies.
Monoclonal antibodies 8G7G3/1 and SPT24, commercially available for thyroid
transcription factor-1 (TTF-1), exhibit varying sensitivities in lung adenocarcinomas
(LADC) and lung squamous cell carcinomas (SqCC). A study by Masai et al. revealed that
SPT24 had much greater sensitivity than 8G7G3/1 in LADC, with rates of 72.4% and
65.4%, respectively. The findings indicated that SPT24 exhibited a greater staining
percentage in lung SqCC (16.8% compared to 1%). The increased sensitivity of SPT24 in
lung squamous cell carcinoma is significantly affected by various detection techniques.
SPT24 can produce greater sensitivity for LADC compared to lung SqCC, relative to
8G7G3/1, while maintaining specificity by the application of a cut-off value and
appropriate antibody titer. In an internal research, SPT24 was titrated to attain negative
staining in normal liver, with no cytoplasmic staining detected. A cut-off threshold of
≥10% of tumor cells exhibiting TTF-1 positivity with a staining intensity of ≥ 1+ was
employed to ascertain TTF-1 positive instances. Employing this methodology, SPT24
shown significant sensitivity for LADC (53/60, 88%), in contrast to 8G7G3/1 (38/60,
63%), although both clones exhibited comparable specificity against lung SqCC (2/137,
1.5%).
The utilization of lung SqCC-specific markers, including Desmoglein 3 and p40, may
discern TTF-1 positive instances of squamous cell genesis. The application of Napsin A
may validate lung adenocarcinoma, as the co-expression of Napsin A and TTF-1 in lung
malignancies has demonstrated more pulmonary specificity than either marker
employed independently. In contrast to clone 8G7G3/1, clone SPT24 has not exhibited
any cytoplasmic staining in lung tumors.
Specifications
Intended Use | RUO |
---|---|
Format | Concentrate, ONCORE Pro, Predilute, Q Series, UltraLine |
Volume | 0.1 ml, 1.0 ml, 20 ml, 6.0 ml, 60 Tests, 7 ml |
Source | Mouse Monoclonal |
Clone | SPT24 |
Isotype | IgG1/kappa |
Antigen | TTF-1 |
Localization | Nuclear |
Positive Control | Lung adenocarcinoma |